
Loading, please wait...

Loading, please wait...

Clinicians often face complex dilemmas when end-of-life care wishes are contested by family members or appointed surrogates. This scenario becomes particularly challenging when a patient loses capacity. While the primary goal is to respect patient autonomy, surrogate decision-makers may sometimes act against documented or previously stated preferences. Consequently, this conflict creates significant moral distress for the medical team. Therefore, practitioners need a structured ethical approach to navigate these sensitive situations.
When a surrogate disagrees with the care team, the first step involves open communication. Frequently, surrogates experience guilt or emotional burden, which clouds their judgment. Thus, clinicians must facilitate detailed family meetings to clarify the patient’s prior values. In the Indian legal landscape, the Supreme Court has provided specific guidelines for Advance Medical Directives. Similarly, doctors should document every step of the mediation process to ensure legal protection. Furthermore, palliative care specialists can offer valuable insights into managing the patient’s comfort while these disputes are resolved.
Moreover, involve hospital ethics committees early. These committees provide a neutral platform for resolution. However, if the surrogate persists in a decision that clearly contradicts known preferences, legal intervention may be necessary. Additionally, understanding the distinction between life-prolonging treatment and comfort care is essential for all parties involved. As a result, clear communication helps in aligning the care plan with the patient's original intent.
Initially, the doctor should attempt to resolve the conflict through multiple family meetings. If the surrogate's decision contradicts the patient's known preferences, the medical team should consult the institutional ethics committee and review local legal guidelines regarding advance directives.
In India, the Supreme Court recognizes the validity of Advance Medical Directives (Living Wills). If a surrogate acts against such a directive or the patient's best interest, the case may require review by a two-tier medical board or judicial intervention as per the latest 2023 guidelines.
Disclaimer: This content is for informational and educational purposes only. It does not constitute legal or medical advice. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A case study exploration of ethical and legal strategies when surrogate decision-makers disagree with a patient's stated hospice care preferences....
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today